ICF foreign fairs target group drug development USA (Q3071752): Difference between revisions
Jump to navigation
Jump to search
(Changed an Item: Edited by the beneficiary bot - attach the beneficiary based on the string) |
(Changed label, description and/or aliases in fr: translated_label) |
||
| label / fr | label / fr | ||
ICF salons étrangers groupe cible développement de médicaments États-Unis | |||
Revision as of 06:57, 26 November 2021
Project Q3071752 in Estonia
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | ICF foreign fairs target group drug development USA |
Project Q3071752 in Estonia |
Statements
32,943.00 Euro
0 references
57,559.0 Euro
0 references
57.23 percent
0 references
1 May 2019
0 references
28 February 2022
0 references
Icosagen Cell Factory OÜ
0 references
58°22'0.84"N, 26°39'47.41"E
0 references
61713
0 references
Icosagen Cell Factory OÜ kommertsialiseerib patenteeritud tehnoloogiaid läbi antikehade arendamise ja tootmise teenuse osutamise diagnostika- ja farmaatsiaettevõtetele. Valitud ärimudeli puhul mõjutab müügitulemusi tehnoloogilisele võimekusele lisaks ka isiklik suhtlus klientidega. USA ravimiarenduse turul suhtevõrgustiku arendamise ja seeläbi teenuse eksportmüügi edendamise peamiseks vahendiks on ettevõtte esitlemine suurimatel USA ravimiarenduse messidel ja konverentsidel. (Estonian)
0 references
Icosagen Cell Factory OÜ commercialises patented technologies through the development and production of antibodies to diagnostic and pharmaceutical companies. In the chosen business model, personal communication with customers not only influences the technological performance of the sales results. The main means of developing a relationship network in the US drug development market, and thereby promoting export sales of the service, is to present the company at the largest US drug development fairs and conferences. (English)
16 August 2021
0 references
Identifiers
2014-2020.5.01.19-1075
0 references